Adaptive Radiation Therapy for Head & Neck Cancer Patients (IGRT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01853670|
Recruitment Status : Completed
First Posted : May 15, 2013
Last Update Posted : March 30, 2015
|Condition or disease||Intervention/treatment||Phase|
|Cancer of Head and Neck||Radiation: concurrent chemo + IGRT Radiation: neoadjuvant chemo + IGRT||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Kilovoltage Conebeam Imaging Based Adaptive Radiation Therapy for Head & Neck Patients Treated With Intensity Modulated Radiation Therapy|
|Study Start Date :||August 2009|
|Actual Primary Completion Date :||January 2015|
|Actual Study Completion Date :||January 2015|
Experimental: definitive radiation + concomitant chemo
Concurrent chemo + IGRT:
These patients will have chemotherapy during the time of radiation treatment
Radiation: concurrent chemo + IGRT
Experimental: neoadjuvant chemo
Neoadjuvant chemo + IGRT:
These patients will have chemotherapy prior to other radiation treatment.
Radiation: neoadjuvant chemo + IGRT
- Clinical patient response [ Time Frame: From the date of initiation of radiation therapy, until date of first progression or until date of death (approximately 5 years). ]This will assessed by CT scan or MRI 4-5 weeks post concurrent chemo.
- Patient quality of life [ Time Frame: During radiation therapy (7-9 weeks) ]This will be assessed using the: Fact Head & Neck form at baseline, and weekly throughout radiation treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01853670
|United States, New York|
|Beth Israel Medical Center|
|New York, New York, United States, 10003|
|Principal Investigator:||Ken Hu, MD||Beth Israel Medical Center|